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were unusual in that their surfaces were
curved, whereas crystals generated by fish
AFP types I and III are hexagonal bipyra-
mids with flat, well-defined facets (Fig. 3
c,d), reflecting, in the case of type-I AFP,
affinity for a specific pyramidal plane10. 
The maximum observed thermal hys-
teresis value (5.5 7C) is four times that
obtained with fish AFPs6. At low concentra-
tions the activity is up to 100 times that of
fish AFPs, consistent with our observations
that THP is a minor constituent of
haemolymph. Contamination with as little
as 0.1–1% THP could produce activities
comparable to those obtained with fish
AFPs, suggesting that past THP prepara-
tions2–5 may have been impure. 
A possible explanation for the hyper-
activity of THP is that the protein has mul-
tiple ice-binding sites and that these sites
either recognize several different features of
ice, or a repeat expressed in several direc-
tions on the ice lattice. These properties
could increase the frequency of THP bind-
ing to ice and might account for the curved
ice crystal surfaces. The fourfold increase in
maximum thermal hysteresis values might
result from closer spacing of THP on the
ice surface11. The exceptional activity of
Tenebrio THP makes it an attractive
reagent for applications requiring freeze
resistance or the control of ice growth and
morphology. 
Laurie A. Graham, Yih-Cherng Liou
Virginia K. Walker, Peter L. Davies
Departments of Biochemistry and Biology,
Queen’s University, Kingston,
Ontario K7L 1N6, Canada
e-mail: daviesp@post.queensu.ca
1. Grimstone, A. V., Mullinger, A. M. & Ramsay, J. A. Phil. Trans.
R. Soc. Lond. B 253, 343–382 (1968).
2. Schneppenheim, R. & Theede, H. Comp. Biochem. Physiol. B 67,
561–568 (1980). 
3. Tomchaney, A. P. et al. Biochemistry 21, 716–721 (1982).
4. Patterson, J. L. & Duman, J. G. J. Exp. Zool. 219, 381–384 (1982).
5. Horwath, K. L., Easton, C. M., Poggioli, G. J., Myers K. &
Schnorr, I. L. Eur. J. Entomol. 93, 419–433 (1996).
6. Davies, P. L. & Hew, C. L. FASEB J. 4, 2460–2468 (1990).
7. Wishart, D. S. et al. Comput. Appl. Biosci. 10, 121–132 (1994).
8. Sönnichsen, F. D., Sykes, B. D. & Davies, P. L. Prot. Sci. 4,
460–471 (1995).
9. DeVries, A. L. Annu. Rev. Physiol. 45, 245–260 (1983).
10.Knight, C. A., Cheng, C. C. & DeVries, A. L. Biophys. J. 59,
409–418 (1991).
11.Wilson, P. W. Cryo-Letters 14, 31–36 (1993).
Role of CED-4 in the
activation of CED-3
Genetic analyses of the nematode Caen-
orhabditis elegans have identified three core
components of the cell-death apparatus1.
CED-3 and CED-4 promote, whereas CED-
9 inhibits cell death. Recent studies indicate
that CED-4 might interact independently
with CED-3 and CED-9, forming the crux
of a multicomponent death complex2. But
except for its role as an adaptor molecule,
little is known about CED-4 function. A
clue came with the observation that muta-
tion of the phosphate-binding loop (P-
loop) of CED-4 disrupts its ability to induce
chromatin condensation in yeast3. Further,
a P-loop mutant of CED-4 (CED-4K165R)
fails to process CED-3 in vivo, both in
insect4 and mammalian cells (unpublished).
We now confirm that CED-4 induces CED-
3 activation and subsequent apoptosis, and
that the process requires binding of ATP.
To test whether CED-4 could bind ATP,
we used ATP analogues that label the
nucleotide-binding sites on proteins. One
such analogue is 58-fluorosulphonyl-
benzoyladenosine (FSBA)5,6. The natural
nucleotide ATP (with Mg2+), effectively
inhibited FSBA incorporation whereas CTP
(with Mg2+) did not (Fig. 1a), showing that
FSBA binds specifically to CED-4. The
photoaffinity ATP analogue 8-azidoadeno-
sine-58-triphosphate[a−32P] (8N3-ATP) has
also been used to identify ATP-binding pro-
teins7,8. As predicted, CED-4 bound 8N3-
ATP and this photoaffinity labelling was
attenuated with  ATP and MgCl2 (Fig. 1b).
Unlike wild-type CED-4, a form of CED-4
(residues 171–549) in which the P-loop
motif was deleted (CED-4DPL), failed to
bind the azido analogue (Fig. 1c).
We next assessed the function of the
CED-4 P-loop, and tested whether CED-4
activates CED-3 in vitro. We prepared
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extracts from 293T cells transfected with
CED-4 or the P-loop mutant CED-4K165R.
We saw proteolytic processing into active
subunits when extracts containing CED-4
were incubated with in vitro translated 35S-
labelled CED-3, but not when incubated
with the CED-3 active-site mutant, CED-
3mt (Fig. 2a). Extracts generated from the
vector or cells transfected with CED-4K165R
also failed to activate CED-3 in vitro (Fig.
2a). When CED-9 or CED-3mt were coex-
pressed with CED-4, CED-4 failed to prote-
olytically activate CED-3 (Fig. 2a).
To rule out the possibility that this phe-
nomenon was due to a possible apoptotic
nature of the CED-4-containing extract, we
depleted CED-4 from the extract using Myc
and histidine affinity tags. When we incu-
bated CED-4-depleted extracts with CED-
3, we found no CED-3 processing (Fig. 2a).
To confirm that CED-4 was responsible
for CED-3 activation, we purified Myc/His
affinity tagged CED-4 from the 293T extract
by Ni2+ chromatography9. Purified CED-4,
but not CED-4K165R, stimulated CED-3 pro-
cessing in vitro, and again the active-site
mutant CED-3mt was not processed by
CED-4 (Fig. 2b), implicating CED-4 as a
catalyst for CED-3 self-processing.
In addition, a peptide inhibitor of cas-
pases, DEVD aldehyde, abrogated CED-4-
mediated auto-processing of CED-3. When
the prodomain of CED-3 was truncated
(CED-3(99–502)), CED-4 was unable to
catalyse CED-3 processing (Fig. 2b). The
prodomain of CED-3 interacts with CED-4
(ref. 10), and this CED-3 prodomain inter-
action with CED-4 seems to be required for
CED-4-mediated activation of CED-3 pro-
cessing. We also show that the ATP analogue
FSBA blocks CED-4-mediated activation of
CED-3 (Fig. 2c), confirming the functional
importance of ATP binding in CED-4 activi-
ty as a catalyst for CED-3 self-processing.
We analysed the C. briggsae CED-4
sequence, and searched the non-redundant
database, to find the highest similarity
(after C. elegans CED-4) with the sequence
Figure 3 Photomicrographs of ice crystals grown in
the presence of THP or AFP. The c-axis is horizon-
tal in the plane of the page in all cases. a, Dilute
haemolymph. b, Recombinant THP. c, Type-I fish
AFP. d, Type-III fish AFP.
Figure 1 CED-4 binds ATP analogues. a, CED-4 binds FSBA, an inhibitor of P-loop-containing ATPases. 35S-
labelled CED-4 was incubated with 1 mM FSBA in DMSO in the presence or absence of excess ATP or CTP
(10 mM) and MgCl2 (10 mM), then immunoprecipitated with rabbit anti-FSBA (Boehringer), followed by
SDS–PAGE. b, CED-4 binds an azido derivative of ATP. Lysates from 293T cells expressing Myc–CED-4 were
incubated with 10 mM (final concentration) 8N3-ATP in the presence or absence of excess ATP (1 mM) and
MgCl2 (1 mM). For azido-affinity labelling, samples were irradiated
7, and then immunoprecipitated with anti-
Myc antibodies (Boehringer) followed by SDS–PAGE and phosphorimager analysis. Control represents
lysates from vector-transfected cells. c, A P-loop deletion mutant of CED-4 fails to bind an azido derivative of
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of the flax rust-resistance protein L6 (Gen-
Bank accession number 862905), a putative
P-loop-containing ATPase11. The alignment
of the C. briggsae CED-4 and L6 sequences
consisted of 322 animo-acids with 23%
identical and 43% similar residues. When
the predicted ATPase domain of L6 was
used to search the non-redundant database
with the PSI-BLAST (position-specific iter-
ative BLAST) program, which enhances
BLAST search with profile analysis12, the
similarity to C. elegans CED-4 was detected
at a statistically significant level (P*1015).
Analysis of a multiple alignment of the
CED-4 sequences with those of plant resis-
tance-response gene products homologous
to L6 (GenBank accession numbers 862905,
1842251, 1086263, 699495, 1931650 and
1513144) showed a consistent pattern of
conservation which was particularly promi-
nent in the P-loop, the putative Mg2+-bind-
ing site, and two additional, downstream
motifs (unpublished). CED-4 and plant-
resistance gene products may contain a
homologous and probably functionally
analogous ATPase domain. 
In summary, CED-4 is central to the reg-
ulation of the molecular framework of cell
death. It has an intrinsic enzymatic activity
which facilitates CED-3 auto-activation and
subsequent apoptosis. CED-3 activation by
CED-4 requires the activity of the putative
CED-4 ATPase domain. The presence of a
conserved ATPase domain in CED-4 and
the plant resistance-response proteins indi-
cates that there may be similarities between
the cell-death machinery and mechanisms
in animals and plants.
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Figure 2 CED-4 facilitates CED-3 auto-activation in vitro. a, Cell extracts expressing CED-4 process in vitro
translated, 35S-labelled CED-3 but not CED-3mt. Myc/His–CED4 was depleted from an extract derived from
CED-4-transfected 293T cells by incubation with Ni2+ beads and further depleted using anti-Myc antibodies
and protein G. 35S-labelled CED-3 was made by in vitro transcription/translation using the TNT rabbit reticulo-
cyte lysate system (Promega; 30 min, 30 °C). Prolonged incubation of the in vitro translate triggered auto-pro-
cessing of CED-3 (ref. 13) and so was avoided. Reactions used 5 ml 35S-labelled CED-3 and 20 ml lysate
containing the indicated proteins, incubated for 1 h at 30 °C. b, Purified CED-4 activates in vitro translated
CED-3. CED-4 and CED-4K165R were purified from transfected 293T cells9. Reactions used ~10–50 ng purified
protein and in vitro translated 35S-labelled CED-3, CED-3mt or CED-3(99–502) incubated for 1 h at 30 °C10.




























































































































































































We report here that applying genetic vectors
onto the skin in a relatively non-invasive
manner can elicit an immune response
against the protein encoded by the vector.
This procedure requires no special skill or
equipment and so may reduce medical costs
and offer a unique method for vaccination.
To elicit a specific immune response, we
anaesthetized mice and removed hair and
cornified epithelium over a restricted area of
abdominal skin using a depilatory (for
example Nair)1. We pipetted roughly 108
plaque-forming units (PFU) of adenovirus
vector in a volume of 10–50 ml onto the pre-
shaved and Nair-treated skin. We allowed the
adenovirus vector to incubate with the naked
skin until the animal recovered from anaes-
thesia, which took between 30 min and 1 h.
After application of AdCMV-hcea, an
adenovirus vector encoding the human car-
cinoembryonic antigen (CEA) gene, onto
the skin of mice (strain C57BL/6), we mon-
itored the production of antibodies against
the human CEA protein by assaying sera
from tail-bleeds. The test sera reacted in
western blots with purified human CEA
protein, but not with bovine serum albu-
min (Fig. 1a). Of 24 vaccinated mice, 23
(96%) produced antibodies against the
human CEA protein after a month, indicat-
ing that specific antibodies were produced
against exogenous proteins encoded by ade-
novirus vectors as a result of the treatment.
Antibodies against adenoviral proteins were
also found in some of the treated animals. 
To test whether this technique might be
generally applicable, we applied AdCMV-
hgmcsf, an adenovirus vector encoding the
human granulocyte macrophage colony
stimulating factor (hGM-CSF), in the same
way. The test sera reacted with purified
human GM-CSF protein (Fig. 1b) in 6 of 14
mice showing that 43% produced antibodies
against the human GM-CSF protein after
application of AdCMV-hgmcsf. Pre-immune
sera collected before treatment, sera from
untreated animals, and sera from animals
treated with AdCMV-luc2 all failed to react
with the human CEA and GM-CSF proteins.
